Setting up a one-stop shop: bringing viral vector manufacturing in-house

Cell & Gene Therapy Insights 2023; 9(3), 311–314

DOI: 10.18609/cgti.2023.049

Published: 17 April 2023
Viewpoint
Danielle Steele


“...developers will have a greater choice of facilities with which to work. There will be more opportunities for collaboration and specialization...”